Allergy Therapeutics Revenue

Allergy Therapeutics had revenue of 36.28M GBP in the half year ending December 31, 2025, with 8.07% growth. This brings the company's revenue in the last twelve months to 57.29M, up 2.94% year-over-year. In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M, down -0.28%.

Revenue (ttm)

57.29M

Revenue Growth

+2.94%

P/S Ratio

11.38

Revenue / Employee

98.11K

Employees

584

Market Cap

652.25M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	55.04M	-155.00K	-0.28%
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HUTCHMED (China)	407.54M
Hikma Pharmaceuticals	2.49B
Shield Therapeutics	36.93M
Venture Life Group	35.17M
ECO Animal Health Group	85.81M
Provexis	871.27K
Haleon	11.03B
Chill Brands Group	370.50K

Revenue Rankings

Allergy Therapeutics News

1 year ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
4 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
6 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz

More News